HVR Cardio, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that it will present data at the 2017 PCR Innovators Day, taking place at ExCel London on 24 September. Clinical Advisor, Professor Bruno Scheller MD, will give a presentation entitled Transcatheter...
HVR Cardio, the cardiovascular device company developing new transformative solutions for mitral valve repair, today announces that HVR Cardio Annuloplasty System initial study data will be presented as an e-poster at the Heart Valve Society Scientific Meeting 2017, taking place between 2-4 March at the...
The statistical analysis of HVR Cardio’s proof-of-concept study evaluating the HVR Cardio Annuloplasty Ring (MAR) has recently been completed. As previously expected based on preliminary data analyses, the main safety- and performance- related objectives of the study were successfully achieved. The newly analyzed results indicate that...
HVR Cardio International Ltd is happy to announce the appointment of Hannu Syrjälä as the new Chairman of its Board of Directors. Mr. Syrjälä succeeds Tord Lendau as Chairman starting from the 14th of September, 2016. Mr. Syrjälä has over twenty years of experience in different...
The long-term data collection for the proof-of-concept study evaluating the HVR Cardio Annuloplasty Ring (MAR) has recently been completed. The prospective single-arm clinical study assessed MAR safety and performance in 11 adults who underwent mitral valve repair surgery. The collected data is currently being analyzed,...
HVR Cardio International Ltd Oy has successfully completed a €8M financing round in March 2015. The round includes a total of €6M in equity from existing and new investors, while the remaining €2M consists of shareholder loans converted into capital. The raised funds will be used...
HVR Cardio International Ltd Oy today announced that the surgeons at Helsinki University Hospital led by Prof Werkkala have successfully continued to recruit patients for the official second phase of the clinical approval study evaluating the safety and efficacy of the “HVR Cardio Helix Ring...